TetohBCL-2 in FVB/N
| Status | Available to order |
| EMMA ID | EM:11139 |
| International strain name | TetohBCL-2 in FVB/N |
| Alternative name | TBCL2.1 in FVB/N |
| Strain type | Transgenic Strains |
| Allele/Transgene symbol | Tg(tetO-BCL2)2.1 |
| Gene/Transgene symbol | Tg(tetO-BCL2)2.1 |
Information from provider
| Provider | Rose Ann Padua |
| Provider affiliation | UMR-S1131, Institut Universitaire d |
| Genetic information | human BCL-2 |
| Phenotypic information | Homozygous:unknownHeterozygous:Normal |
| Breeding history | I have been breeding these mice since 1999 |
| References |
|
| Homozygous fertile | not known |
| Homozygous viable | not known |
| Homozygous matings required | no |
| Immunocompromised | no |
Information from EMMA
| Archiving centre | Institut de Transgenose, INTRAGENE, Orléans, France |
| Animals used for archiving | heterozygous FVB/N |
Literature references
- BCL-2 and mutant NRAS interact physically and functionally in a mouse model of progressive myelodysplasia.;Omidvar Nader, Kogan Scott, Beurlet Stephanie, le Pogam Carole, Janin Anne, West Robert, Noguera Maria-Elena, Reboul Murielle, Soulie Annie, Leboeuf Christophe, Setterblad Niclas, Felsher Dean, Lagasse Eric, Mohamedali Azim, Thomas N Shaun B, Fenaux Pierre, Fontenay Michaela, Pla Marika, Mufti Ghulam J, Weissman Irving, Chomienne Christine, Padua Rose Ann, ;2007;Cancer research;67;11657-67; 18089795